ENTITY
Grifols SA

Grifols SA (GRF SM)

95
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bearish•Grifols SA
•17 Sep 2026 13:02

Grifols SA (GRF SM): Synthetic Expert Call Transcript (17 Sep 2026)

Simplifying the dual-class share structure (Class A to Class B discount) is legally and structurally locked. Under Spanish corporate law, any...

Share
bullish•Grifols SA
•17 Sep 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: September '26 Report

September brought fresh dispersion: Carlsberg, Grifols and MFE widened sharply, improving convergence returns, while Ericsson's B-only buyback adds...

Share
bullish•Grifols SA
•08 Aug 2026 07:44

Primer: Grifols SA (GRF SM) - Aug 2026

Grifols is a global leader in the plasma-derived medicines industry, an oligopolistic market with high barriers to entry. The company is...

Logo
102 Views
Share
•17 Aug 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: August '26 Report

August brought fresh dispersion across Europe's dual-class shares, creating new relative-value opportunities while corporate actions remain an...

Share
•16 Jul 2026 17:02

Liquid Universe of European Ordinary and Preferred Shares: July '26 Report

-July widened dispersion across Europe’s dual-class universe, yet selective convergence persisted beneath the surface. Structural anomalies...

Share
x